Abstract
Negative selection in thymus occurs by apoptosis in CD4+CD81 cells. These immature thymocytes are readily killed, both in vitro and in vivo, by glucocorticoid treatment. Increased levels of intracellular cAMP in vitro also induce apoptosis of thymocytes and T cell receptor (TcR) stimulation potentiate cAMP responses through receptors linked to adenylic cyclase. Presently, we have tested the possibility that TcR‐mediated apoptosis in vivo may require the glucocorticoid receptor (GR) as a downstream, intracellular mediator. Use of the GR antagonist RU‐486, 24 h before and simultaneous with, anti‐CD3 or 5′‐(N‐ethyl)‐carboxamide‐adenosine (NECA) treatment, resulted in a selective inhibition of CD4+CD8+ thymocyte death. In addition, a low dose of glucocorticoid potentiated thymocyte death induced by anti‐CD3 monoclonal antibodies. These data support a model in which thymic negative selection depends on a defined set of transduction signals which potentiate the GR to become responsive to endogenous levels of glucocorticoid.
Original language | English (US) |
---|---|
Pages (from-to) | 1246-1250 |
Number of pages | 5 |
Journal | European Journal of Immunology |
Volume | 23 |
Issue number | 6 |
DOIs | |
State | Published - Jun 1993 |
Externally published | Yes |
Keywords
- Apoptosis
- Glucocorticoid
- T cell receptor
- Thymocyte
- cAMP
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology